ECM
MRTX

Endurant Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Endurant Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,915
Closed -$553K – 76
2022
Q3 		$553K Buy
+7,915
New +$553K 0.18% 44